US Heart Failure Devices Market Analysis, 2024–2034

The US Heart Failure Devices Market Analysis Executive Summary

Heart failure devices help weak hearts pump or keep rhythm, including pumps, defibrillators, resynchronisation devices and sensors.

Key segments of the heart Failure Devices market include device (Ventricular Assist Devices, CRT Devices and ICDs) and use (Bridge to Transplant, Destination Therapy and Monitoring).

US Heart Failure Devices Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the heart Failure Devices market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the heart Failure Devices market.

Competitive Landscape for Heart Failure Devices Market in US

The heart Failure Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

• AAbbott Laboratories
• Medtronic
• Boston Scientific
• AAbiomed (Johnson & Johnson)
• IImpulse Dynamics

Healthcare Policies and Regulatory Landscape for Heart Failure Devices Market in US

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how heart Failure Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.

1. 1 Market Analysis

   • 1.1 Research Scope and Assumption
   • 1.2 Objective of the study
   • 1.3 Research Methodology
   • 1.4 Reason to buy the report

2. 2 Market Analysis Executive Summary

   • 2.1 Market Analysis - Industry Snapshot & key buying criteria, 2025-2034
   • 2.2 Market Size, Growth Prospects and Key findings

3. 3 Market Dynamics

   • 3.1 Market Growth Drivers Analysis
   • 3.2 Market Restraints Analysis

4. 4 Market Segmentation

   • 4.1 By Device
   • 4.2 By Use
   • 4.3 By End User

5. 5 By Market Share

   • 5.1 Market Analysis, Insights and Forecast – By Revenue

6. 6 Competitive Landscape

   • 6.1 Major Top Market Players Products in Pipeline
   • 6.2 R&D Initiatives
   • 6.3 Notable recent Deals
   • 6.3.1 Strategic Divestments
   • 6.3.2 Mergers & Acquisitions
   • 6.3.3 Partnerships
   • 6.3.4 Joint Ventures

7. 7 Key Company Profiles

   • 7.1 Abbott Laboratories
   • 7.2 Medtronic
   • 7.3 Boston Scientific
   • 7.4 Abiomed (Johnson & Johnson)
   • 7.5 Impulse Dynamics

8. 8 Healthcare Policies and Regulatory Landscape

   • 8.1 Policy changes and Reimbursement scenario
   • 8.2 Government Initiatives / Intervention programs

The heart Failure Devices market can be segmented based on various criteria, including device, use and end user. Here's a breakdown of the market segmentation